Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications

Journal of Biosciences

Volumn 28, Issue 6, 2003, Pages 715-721

  Balasubramanyam, M ^a   Koteswari, A Adaikala ^a   Kumar, R Sampath ^a   Monickaraj, S Finny ^a   Maheswari, J Uma ^a   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Curcumin; Diabetes; Oxidative stress; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; CALCIUM ION; CURCUMIN; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; THAPSIGARGIN;

DIABETES; OXIDATION;

ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DOSE RESPONSE; HUMAN; HUMAN CELL; OXIDATIVE STRESS;

CURCUMA; CURCUMA LONGA;

EID: 0346243915     PISSN: 02505991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02708432     Document Type: Article

References (37)

1. Abe Y, Hashimoto S and Horie T 1999 Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages; Pharmacol. Res. 39 41-47.
2. Aggarwal B B, Kumar A and Bharti A C 2003 Anticancer potential of curcumin: preclinical and clinical studies; Anticancer Res. 23 363-398
3. Armstrong D, Ueda T, Aljada A, Browne R, Fukuda S, Spengler R, Chou R, Hartnett M, Buch P, Dandona P, Sasisekharan R and Dorey C K 1998 Lipid hydroperoxide stimulates retinal neovascularisation in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor; Angiogenesis 2 93-104
4. Balasubramanyam M, Kimura M, Aviv A and Gardner J P 1993 Kinetics of calcium transport across the lymphocyte plasma membrane; Am. J. Physiol. 265 C321-C327
5. 2+ homeostasis in type 2 diabetes mellitus; Int. J. Exp. Diabetes Res. 1 275-287
6. Balasubramanyam M and Mohan V 2002 The need for high throughput screening of herbal medicine with special reference to diabetes mellitus; in Biodiversity (monitoring, management, conservation and enhancement) (eds) R Ramamurthi and G Bali (New Delhi: APH Publishing Corp.) pp 57-74
7. 2+ Fluxes; Diabetes (Suppl. 2) 54 A449
8. Baynes J W 1991 Role of oxidative stress in development of complications in diabetes; Diabetes 40 405-412
9. Bierhaus A, Zhang Y, Quehenberger P, Luther T, Haase M, Muller M, Mackman N, Ziegler R and Nawroth P P 1997 The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B; Thromb. Haemost. 77 772-782
10. 2+ pumps by curcumin; Eur. J. Biochem. 268 6318-6327
11. Bonnefont-Rousselot D 2002 Glucose and reactive oxygen species; Curr. Opin. Clin. Nutr. Metab. Care 5 561-568
12. Brownlee M 2001 Biochemistry and molecular cell biology of diabetic complications; Nature (London) 414 813-820
13. Ceriello A 2003 New insights on oxidative stress and diabetic complications may lead to a "Causal" antioxidant therapy; Diabetes Care 26 1589-1596
14. Chainani-Wu N 2003 Safety and anti-inflammatory activity of curcumin: A component of turmeric (Curcuma longa); J. Altern. Complement. Med. 9 161-168
15. 2+ ion and cellular p53 protein by curcumin in colorectal carcinoma cells; Mol. Carcinog. 17 224-234
16. Chen H W and Huang H C 1998 Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells; Br. J. Pharmacol. 124 1029-1040
17. Cheng A L, Hsu C H, Lin J K, Hsu M M, Ho Y F, Shen T S, Ko J Y, Lin J T, Lin B R, Ming-Shiang W, Yu H S, Jee S H, Chen G S, Chen T M, Chen C A, Lai M K, Pu Y S, Pan M H, Wang Y J, Tsai C C and Hsieh C Y 2001 Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions; Anticancer Res. 21 2895-2900
18. Dyer J L, Khan S Z, Bilmen J G, Hawtin S R, Wheatley M, Javed M U and Michelangeli F 2002 Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor; Cell Calcium 31 45-52
19. Frank R N 2002 Potential new medical therapies for Diabetic Retinopathy: Protein Kinase C inhibitors; Am. J. Ophthalmol. 133 693-698
20. Gopalakrishna R and Jaken S 2000 Protein Kinase C signalling and oxidative stress; Free Radic. Biol. Med. 28 1349-1361
21. Kowluru R A 2001 Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated; Acta Diabetol. 38 179-185
22. Lee T S, Saltsman K A, Ohashi H and King G L 1989 Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications; Proc. Natl. Acad. Sci. USA 86 5141-5145
23. Liu J Y, Lin S J and Lin J K 1993 Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells; Carcinogenesis 14 857-861
24. Martens F M, Visseren F L, Lemay J, de Koning E J and Rabelink T J 2002 Metabolic and additional vascular effects of thioazolidinediones; Drugs 62 1463-1480
25. Mercuri F, Quagliaro L and Ceriello A 2000 Oxidative stress evaluation in diabetes; Diabetes Technol. Ther. 2 589-600
26. Ohno S and Nishizuka Y 2002 Protein kinase C Isotypes and their specific functions: Prologue; J. Biochem. 132 509-511
27. Okamoto T, Yamagishi S, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A and Makita Z 2002 Angiogenesis induced by advanced glycation end products and its prevention by cerivastin; FASEB J. 16 1928-1930
28. Palmer H J and Paulson K E 1997 Reactive oxygen species and antioxidants in signal Transduction and gene expression; Nutr. Rev. 55 353-361
29. Piwocka K, Zablocki K, Wieckowski M R, Skierski J, Feiga I, Szopa J, Derla N, Wojtczak L and Sikora E 1999 A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells; Exp. Cell. Res. 249 299-307
30. Rosen P, Nawroth P P, King G, Moller W, Tritschler H-J and Packer L 2001 The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society; Diabetes Metab. Res. Rev. 17 189-212
31. 2+ signalling; Biochem. Pharmacol. 58 1167-1172
32. Srinivasan K R 1953 Chromatographic study of the curcuminoids in Curcuma longa; J. Pharma. Pharmacol. 5 448
33. Srivastava K C, Bordia A and Verma S K 1995 Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets; Protaglandins Leukot. Essent. Fatty Acids 52 223-227
34. 2 for PDGF signal transduction; Science 270 296-299
35. 2+-ATPase; Proc. Natl. Acad. Sci. USA 87 2466-2470
36. Xu J, Fu Y and Chen A 2003 Activation of peroxisome proliferator-activated receptor-(gamma) contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth; Am. J. Physiol. 285 G20-G30
37. Zhang F, Altorki N K, Mestre J R, Subbaramaiah K and Dannenberg A J 1999 Curcumin inhibits cyclooxygenase-2 transrcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells; Carcinogenesis 20 445-451